Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Biogeneric Debate Likely For 2007 Congressional Session

Dec. 26, 2006

By Aaron Lorenzo

Industry Mulling Movement Toward Price Transparency

Dec. 22, 2006

By Aaron Lorenzo

Industry Mulling Movement Toward Price Transparency

Dec. 22, 2006

By Aaron Lorenzo

Orexigen Files IPO To Fund Its Obesity-Fighting Drugs

Dec. 21, 2006

By Aaron Lorenzo

HHS Ends VaxGen's $877.5M Contract On Anthrax Vaccine

Dec. 21, 2006

By Aaron Lorenzo

HHS Ends VaxGen's $877.5M Contract On Anthrax Vaccine

Dec. 21, 2006

By Aaron Lorenzo

Orexigen Files IPO To Fund Its Obesity-Fighting Drugs

Dec. 21, 2006

By Aaron Lorenzo

Orphan Pressing Ahead With Lucassin NDA For Type I HRS

Dec. 20, 2006

By Aaron Lorenzo

Orphan Pressing Ahead With Lucassin NDA For Type I HRS

Dec. 20, 2006

By Aaron Lorenzo

FDA Gives Nod To BioSante's Estrogen Drug In Hot Flashes

Dec. 19, 2006

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...